Literature DB >> 17389502

Identification of novel dendritic cell populations in normal mouse retina.

Heping Xu1, Rosemary Dawson, John V Forrester, Janet Liversidge.   

Abstract

PURPOSE: Whether tissue resident or infiltrating antigen-presenting cells (APCs) are involved in modulating immune responses in the retina and initiating inflammation is controversial. In this histologic study, the authors examine the retinas of mice strains with different susceptibility to experimental autoimmune uveoretinitis (EAU) for tissue resident APC.
METHODS: Retinal wholemounts from normal and inflamed eyes of B10R III, C57BL/6, BALB/c, and ABH Biozii mice were immunostained for APC markers (33D1, CD11c, CD11b, major histocompatibility complex [MHC] class II, F4/80, CD80, CD86, CD205, mPDCA, B220, and GR1) and analyzed by confocal fluorescence microscopy using emission fingerprinting and three-dimensional reconstruction techniques. Hematoxylin and eosin-stained histologic sections were used to evaluate EAU disease scores and to assess outer blood retina barrier (retinal pigment epithelium [RPE]) structures.
RESULTS: A population of 33D1(+) cells was identified exclusively in the peripheral margins and juxtapapillary areas of the retina in normal, nonimmunized C57BL/6 adult mice. These cells were also MHC class II(high), and their location corresponded to sites of earliest inflammation in EAU. Numbers in the papillary area were very low (less than 10), but this region marked the predominant anatomic site for initiation of inflammation in this moderately susceptible strain. The distribution and phenotype of these cells within the retinas differed between mouse strains exhibiting different disease susceptibility. In EAU-resistant BALB/c mice, many more 33D1(+) dendritic cells were present in the normal retina but were MHC class II(low/-). Conversely, no 33D1(+) or MHC class II (+) dendriform cells could be found in the normal retinas of highly EAU-susceptible B10.RIII mice.
CONCLUSIONS: A novel population of 33D1(+) DCs was identified in normal mouse retina. The function of these cells remains to be defined, but increased numbers correlate positively with structural abnormalities in the RPE and increased resistance of the strain to EAU.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17389502      PMCID: PMC2446435          DOI: 10.1167/iovs.06-0697

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  49 in total

1.  Lack of blood-brain barrier properties in microvessels of the prelaminar optic nerve head.

Authors:  P Hofman; P Hoyng; F vanderWerf; G F Vrensen; R O Schlingemann
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-04       Impact factor: 4.799

2.  Breakdown of the blood-retinal barrier induced by activated T cells of nonneural specificity.

Authors:  P Hu; J D Pollard; T Chan-Ling
Journal:  Am J Pathol       Date:  2000-04       Impact factor: 4.307

Review 3.  Retinal pigment epithelium-immune system interactions: cytokine production and cytokine-induced changes.

Authors:  G M Holtkamp; A Kijlstra; R Peek; A F de Vos
Journal:  Prog Retin Eye Res       Date:  2001-01       Impact factor: 21.198

4.  TGF-beta 1 synergizes with GM-CSF to promote the generation of glial cell-derived dendriform cells in vitro.

Authors:  Bao-Guo Xiao; Ling-Yun Xu; Jian-She Yang
Journal:  Brain Behav Immun       Date:  2002-12       Impact factor: 7.217

5.  Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis.

Authors:  Cathryn Broderick; Robert M Hoek; John V Forrester; Janet Liversidge; Jonathon D Sedgwick; Andrew D Dick
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

6.  Dendritic cells and macrophages in the uveal tract of the normal mouse eye.

Authors:  P G McMenamin
Journal:  Br J Ophthalmol       Date:  1999-05       Impact factor: 4.638

7.  Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice.

Authors:  H R Jiang; L Lumsden; J V Forrester
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-12       Impact factor: 4.799

8.  Localization and characterization of immunocompetent cells in the human retina.

Authors:  P Yang; P K Das; A Kijlstra
Journal:  Ocul Immunol Inflamm       Date:  2000-09       Impact factor: 3.070

9.  Leukocyte trafficking in experimental autoimmune uveitis: breakdown of blood-retinal barrier and upregulation of cellular adhesion molecules.

Authors:  Heping Xu; John V Forrester; Janet Liversidge; Isabel J Crane
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-01       Impact factor: 4.799

10.  Experimental autoimmune uveoretinitis in mice (Biozzi ABH and NOD) expressing the autoimmune-associated H-2A(g7) molecule: identification of a uveitogenic epitope.

Authors:  D J Hankey; J M Nickerson; L A Donoso; S L Lightman; D Baker
Journal:  J Neuroimmunol       Date:  2001-08-30       Impact factor: 3.478

View more
  35 in total

1.  Characterization of a mouse model of hyperglycemia and retinal neovascularization.

Authors:  Elizabeth P Rakoczy; Ireni S Ali Rahman; Nicolette Binz; Cai-Rui Li; Nermina N Vagaja; Marisa de Pinho; Chooi-May Lai
Journal:  Am J Pathol       Date:  2010-09-09       Impact factor: 4.307

2.  Dendritic cells are early responders to retinal injury.

Authors:  Ute Lehmann; Neal D Heuss; Scott W McPherson; Heidi Roehrich; Dale S Gregerson
Journal:  Neurobiol Dis       Date:  2010-05-23       Impact factor: 5.996

3.  Local activation of dendritic cells alters the pathogenesis of autoimmune disease in the retina.

Authors:  Neal D Heuss; Ute Lehmann; Christopher C Norbury; Scott W McPherson; Dale S Gregerson
Journal:  J Immunol       Date:  2012-01-04       Impact factor: 5.422

4.  TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation.

Authors:  Holly R Chinnery; Samuel McLenachan; Nicolette Binz; Yan Sun; John V Forrester; Mariapia A Degli-Esposti; Eric Pearlman; Paul G McMenamin
Journal:  Am J Pathol       Date:  2011-11-12       Impact factor: 4.307

5.  MHC class II expression and potential antigen-presenting cells in the retina during experimental autoimmune uveitis.

Authors:  Deborah A Lipski; Rémi Dewispelaere; Vincent Foucart; Laure E Caspers; Matthieu Defrance; Catherine Bruyns; François Willermain
Journal:  J Neuroinflammation       Date:  2017-07-18       Impact factor: 8.322

6.  Neurons preferentially respond to self-MHC class I allele products regardless of peptide presented.

Authors:  Nathalie Escande-Beillard; Lorraine Washburn; Dan Zekzer; Zhongqi-Phyllis Wu; Shoshy Eitan; Sonja Ivkovic; Yuxin Lu; Hoa Dang; Blake Middleton; Tina V Bilousova; Yoshitaka Yoshimura; Christopher J Evans; Sebastian Joyce; Jide Tian; Daniel L Kaufman
Journal:  J Immunol       Date:  2009-12-16       Impact factor: 5.422

7.  GM-CSF regulates intimal cell proliferation in nascent atherosclerotic lesions.

Authors:  Su-Ning Zhu; Mian Chen; Jenny Jongstra-Bilen; Myron I Cybulsky
Journal:  J Exp Med       Date:  2009-09-14       Impact factor: 14.307

8.  Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.

Authors:  Guomin Jiang; Yan Ke; Deming Sun; Gencheng Han; Henry J Kaplan; Hui Shao
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

9.  γδ T cells as a major source of IL-17 production during age-dependent RPE degeneration.

Authors:  Zhenyang Zhao; Pei Xu; Zuliang Jie; Yiqin Zuo; Bo Yu; Lynn Soong; Jiaren Sun; Yan Chen; Jiyang Cai
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-11       Impact factor: 4.799

10.  CD4 T-cell suppression by cells from Toxoplasma gondii-infected retinas is mediated by surface protein PD-L1.

Authors:  Elizabeth Charles; Sunil Joshi; John D Ash; Barbara A Fox; A Darise Farris; David J Bzik; Mark L Lang; Ira J Blader
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.